Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

Orbimed Advisors LLC reported a 13.80% stake in Corvus Pharmaceuticals, Inc. (Schedule 13D/A)

Event Apr 29, 2025 · Filed May 1, 2025

Orbimed Advisors LLC reported a 13.80% stake in Corvus Pharmaceuticals, Inc., 9,785,423 shares, with active intent on Apr 29, 2025. Filed May 1, 2025 (Schedule 13D/A).

Stake
13.80%
Shares
9,785,423
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC13.80%9,785,423
ORBIMED CAPITAL GP V LLC13.80%9,785,423

Source

View original at SEC

Related